Defining Pathways for Development of Disease-Modifying Therapies in Children With Type 1 Diabetes: A Consensus Report

被引:63
作者
Wherrett, Diane K. [1 ]
Chiang, Jane L. [2 ]
Delamater, Alan M. [3 ]
DiMeglio, Linda A. [4 ]
Gitelman, Stephen E. [5 ]
Gottlieb, Peter A. [6 ,7 ]
Herold, Kevan C. [8 ]
Lovell, Daniel J. [9 ]
Orchard, Trevor J. [10 ]
Ryan, Christopher M. [11 ]
Schatz, Desmond A. [12 ]
Wendler, David S. [13 ]
Greenbaum, Carla J. [14 ]
机构
[1] Univ Toronto, Dept Pediat, Toronto, ON, Canada
[2] Amer Diabet Assoc, Alexandria, VA USA
[3] Univ Miami, Dept Pediat, Miami, FL 33152 USA
[4] Indiana Univ, Dept Pediat, Indianapolis, IN 46204 USA
[5] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA
[6] Univ Colorado, Dept Med, Denver, CO USA
[7] Univ Colorado, Dept Pediat, Denver, CO 80202 USA
[8] Yale Univ, Dept Immunobiol, New Haven, CT USA
[9] Cincinnati Childrens Hosp Med Ctr, Div Rheumatol, Cincinnati, OH 45229 USA
[10] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA
[11] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA
[12] Univ Florida, Dept Pediat, Gainesville, FL USA
[13] NIH, Dept Bioeth, Bethesda, MD 20892 USA
[14] Benaroya Res Inst, Diabet Res Program, Seattle, WA 98101 USA
关键词
QUALITY-OF-LIFE; RANDOMIZED CONTROLLED-TRIAL; PRESERVES C-PEPTIDE; BETA-CELL FUNCTION; PITTSBURGH EPIDEMIOLOGY; DOUBLE-BLIND; PEDIATRIC RESEARCH; GLYCEMIC CONTROL; RISK-FACTORS; NATURAL-HISTORY;
D O I
10.2337/dc15-1429
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Emerging data suggest that type 1 diabetes is a more aggressive disease in children than in adults, with important differences in pathophysiology and clinical course. Therefore, the efficacy of disease-modifying therapies may be different in the two populations. Understanding the developmental and regulatory pathways for type 1 diabetes-modifying therapies in children will enable industry, academia, funders, advocacy groups, and regulators to translate new science to clinical care. This consensus report characterizes the fundamental differences in type 1 diabetes between children and adults and proposes a thoughtful approach to better understand the development and regulatory pathways for type 1 diabetes therapies.
引用
收藏
页码:1975 / 1985
页数:11
相关论文
共 96 条
[1]   Strategies for Improving Care [J].
不详 .
DIABETES CARE, 2015, 38 :S5-S7
[2]  
[Anonymous], 2014 NAT DIAB STAT R
[3]   Alterations in White Matter Structure in Young Children With Type 1 Diabetes [J].
Barnea-Goraly, Naama ;
Raman, Mira ;
Mazaika, Paul ;
Marzelli, Matthew ;
Hershey, Tamara ;
Weinzimer, Stuart A. ;
Aye, Tandy ;
Buckingham, Bruce ;
Mauras, Nelly ;
White, Neil H. ;
Fox, Larry A. ;
Tansey, Michael ;
Beck, Roy W. ;
Ruedy, Katrina J. ;
Kollman, Craig ;
Cheng, Peiyao ;
Reiss, Allan L. .
DIABETES CARE, 2014, 37 (02) :332-340
[4]   Improvement in Outcomes of Clinical Islet Transplantation: 1999-2010 [J].
Barton, Franca B. ;
Rickels, Michael R. ;
Alejandro, Rodolfo ;
Hering, Bernhard J. ;
Wease, Stephen ;
Naziruddin, Bashoo ;
Oberholzer, Jose ;
Odorico, Jon S. ;
Garfinkel, Marc R. ;
Levy, Marlon ;
Pattou, Francois ;
Berney, Thierry ;
Secchi, Antonio ;
Messinger, Shari ;
Senior, Peter A. ;
Maffi, Paola ;
Posselt, Andrew ;
Stock, Peter G. ;
Kaufman, Dixon B. ;
Luo, Xunrong ;
Kandeel, Fouad ;
Cagliero, Enrico ;
Turgeon, Nicole A. ;
Witkowski, Piotr ;
Naji, Ali ;
O'Connell, Philip J. ;
Greenbaum, Carla ;
Kudva, Yogish C. ;
Brayman, Kenneth L. ;
Aull, Meredith J. ;
Larsen, Christian ;
Kay, Tom W. H. ;
Fernandez, Luis A. ;
Vantyghem, Marie-Christine ;
Bellin, Melena ;
Shapiro, A. M. James .
DIABETES CARE, 2012, 35 (07) :1436-1445
[5]   Predicting Type 1 Diabetes Using Biomarkers [J].
Bonifacio, Ezio .
DIABETES CARE, 2015, 38 (06) :989-996
[6]   Validation of a diabetes-specific quality-of-life scale for patients with type 1 diabetes [J].
Bott, U ;
Mühlhauser, I ;
Overmann, H ;
Berger, M .
DIABETES CARE, 1998, 21 (05) :757-769
[7]   The effects of type 1 diabetes on cognitive performance - A meta-analysis [J].
Brands, AMA ;
Biessels, GJ ;
De Haan, EHF ;
Kappelle, LJ ;
Kessels, RPC .
DIABETES CARE, 2005, 28 (03) :726-735
[8]   Effectiveness of Early Intensive Therapy on β-Cell Preservation in Type 1 Diabetes [J].
Buckingham, Bruce ;
Beck, Roy W. ;
Ruedy, Katrina J. ;
Cheng, Peiyao ;
Kollman, Craig ;
Weinzimer, Stuart A. ;
DiMeglio, Linda A. ;
Bremer, Andrew A. ;
Slover, Robert ;
Tamborlane, William V. .
DIABETES CARE, 2013, 36 (12) :4030-4035
[9]   Effect of docosahexaenoic acid supplementation on inflammatory cytokine levels in infants at high genetic risk for type 1 diabetes [J].
Chase, H. Peter ;
Boulware, David ;
Rodriguez, Henry ;
Donaldson, David ;
Chritton, Sonia ;
Rafkin-Mervis, Lisa ;
Krischer, Jeffrey ;
Skyler, Jay S. ;
Clare-Salzler, Michael .
PEDIATRIC DIABETES, 2015, 16 (04) :271-279
[10]   Trends in the Prevalence of Ketoacidosis at Diabetes Diagnosis: The SEARCH for Diabetes in Youth Study [J].
Dabelea, Dana ;
Rewers, Arleta ;
Stafford, Jeanette M. ;
Standiford, Debra A. ;
Lawrence, Jean M. ;
Saydah, Sharon ;
Imperatore, Giuseppina ;
D'Agostino, Ralph B., Jr. ;
Mayer-Davis, Elizabeth J. ;
Pihoker, Catherine .
PEDIATRICS, 2014, 133 (04) :E938-E945